Sub Q Entyvio Hits Speed Bump After US Complete Response
Queries ‘Unrelated’ To Clinical Data
Questions from FDA may delay progress to US approval of Takeda's more convenient formulation of blockbuster Entyvio.
Questions from FDA may delay progress to US approval of Takeda's more convenient formulation of blockbuster Entyvio.